Lai PL - Search Results

1

Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients.

Hsu HC, Peng SY, Lai PL, Sheu JC, Chen DS, Lin LI, Slagle BL, Butel JS. Hsu HC, et al. Among authors: lai pl. Cancer. 1994 Jan 1;73(1):42-7. doi: 10.1002/1097-0142(19940101)73:1<42::aid-cncr2820730109>3.0.co;2-d. Cancer. 1994. PMID: 7506118

2

Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.

Lee YC, Pan HW, Peng SY, Lai PL, Kuo WS, Ou YH, Hsu HC. Lee YC, et al. Among authors: lai pl. Eur J Cancer. 2007 Mar;43(4):736-44. doi: 10.1016/j.ejca.2006.11.020. Epub 2007 Jan 30. Eur J Cancer. 2007. PMID: 17267202

3

Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance.

Peng SY, Lai PL, Hsu HC. Peng SY, et al. Among authors: lai pl. J Formos Med Assoc. 1993 Oct;92(10):866-70. J Formos Med Assoc. 1993. PMID: 7511953

4

Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas.

Peng SY, Lai PL, Chu JS, Lee PH, Tsung PT, Chen DS, Hsu HC. Peng SY, et al. Among authors: lai pl. Hepatology. 1993 Jan;17(1):35-41. Hepatology. 1993. PMID: 7678574

5

Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma.

Hsu HC, Huang AM, Lai PL, Chien WM, Peng SY, Lin SW. Hsu HC, et al. Among authors: lai pl. Hepatology. 1994 Jan;19(1):122-8. Hepatology. 1994. PMID: 7903951

6

Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.

Hsu HC, Tseng HJ, Lai PL, Lee PH, Peng SY. Hsu HC, et al. Among authors: lai pl. Cancer Res. 1993 Oct 1;53(19):4691-4. Cancer Res. 1993. PMID: 8402647

7

Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.

Hsu HC, Cheng W, Lai PL. Hsu HC, et al. Among authors: lai pl. Cancer Res. 1997 Nov 15;57(22):5179-84. Cancer Res. 1997. PMID: 9371521

8

Mutations of p53 gene in hepatocellular-carcinoma (hcc) correlate with tumor progression and patient prognosis - a study of 138 patients with unifocal hcc.

Hsu H, Peng S, Lai P, Chu J, Lee P. Hsu H, et al. Int J Oncol. 1994 Jun;4(6):1341-7. doi: 10.3892/ijo.4.6.1341. Int J Oncol. 1994. PMID: 21567059

9

Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.

Yuan RH, Jeng YM, Chen HL, Lai PL, Pan HW, Hsieh FJ, Lin CY, Lee PH, Hsu HC. Yuan RH, et al. Among authors: lai pl. J Pathol. 2006 Aug;209(4):549-58. doi: 10.1002/path.2011. J Pathol. 2006. PMID: 16739096

10

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.

Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY. Hsu HC, et al. Among authors: lai pl. Am J Pathol. 2000 Sep;157(3):763-70. doi: 10.1016/s0002-9440(10)64590-7. Am J Pathol. 2000. PMID: 10980116 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters